JOSEPH LUBEGA to Immunoglobulins, Intravenous
This is a "connection" page, showing publications JOSEPH LUBEGA has written about Immunoglobulins, Intravenous.
Connection Strength
0.043
-
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
Score: 0.043